Individual dose prescription and dose escalation with intraoperative radiotherapy (IORT) in patients with soft tissue sarcomas of the limb to counteract risk factors for local recurrence

被引：0
|
作者：
Roeper, B. [1 ]
Rechl, H. [2 ]
Schindler, E. M. [3 ]
Hadjamu, M. [1 ]
Winkler, C. [1 ]
Kneschaurek, P. [1 ]
Molls, M. [1 ]
Gradinger, R. [2 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Klin Strahlentherapie & Radiol Onkol, D-8000 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopadie & Unfallchirurg, D-8000 Munich, Germany
[3] Klinikum Starnberg, Klin Orthopadie, Starnberg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2011年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 49 条
  • [31] Single institution experience with preoperative hypofractionated radiation and concurrent dose-intense chemotherapy for patients with high-risk soft tissue sarcomas
    Hung, A. Y.
    Hayden, J. B.
    Mansoor, A.
    Vetto, J.
    Sauser, D.
    Ryan, C. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S120 - S120
  • [32] Examining the Relationship between the Location of Local Tumor Recurrence and the Radiotherapy Treatment Volume for Extremity Soft Tissue Sarcoma Patients Treated with Limb Salvage Surgery and External Beam Radiotherapy
    Dickie, C. I.
    Parent, A.
    Griffin, A.
    Panzarella, T.
    Ferguson, P.
    Wunder, J.
    Sharpe, M.
    Chung, P.
    Catton, C.
    O'Sullivan, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S65 - S66
  • [33] Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas A Nonrandomized Phase 1/2 Clinical Trial
    Martin-Broto, Javier
    Hindi, Nadia
    Lopez-Pousa, Antonio
    Peinado-Serrano, Javier
    Alvarez, Rosa
    Alvarez-Gonzalez, Ana
    Italiano, Antoine
    Sargos, Paul
    Cruz-Jurado, Josefina
    Isern-Verdum, Josep
    Dolado, Maria Carmen
    Rincon-Perez, Inmaculada
    Sanchez-Bustos, Paloma
    Gutierrez, Antonio
    Romagosa, Cleofe
    Morosi, Carlo
    Grignani, Giovanni
    Gatti, Marco
    Luna, Pablo
    Alastuey, Ignacio
    Redondo, Andres
    Belinchon, Belen
    Martinez-Serra, Jordi
    Sunyach, Marie-Pierre
    Coindre, Jean-Michel
    Dei Tos, Angelo P.
    Romero, Jesus
    Gronchi, Alessandro
    Blay, Jean-Yves
    Moura, David S.
    JAMA ONCOLOGY, 2020, 6 (04) : 535 - 541
  • [34] FDG-PET for the prediction of therapy outcome in patients with high risk soft tissue sarcomas receiving high dose chemotherapy with stem cell rescue.
    Wuchter, P.
    Kasper, B.
    Dimitrakopoulou-Strauss, A.
    Egerer, G.
    Haberkorn, U.
    Ho, A. D.
    Strauss, L. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 535S - 535S
  • [35] Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model
    Willeumier, Julie J.
    Rueten-Budde, Anja J.
    Jeys, Lee M.
    Laitinen, Minna
    Pollock, Rob
    Aston, Will
    Dijkstra, P. D. Sander
    Ferguson, Peter C.
    Griffin, Anthony M.
    Wunder, Jay S.
    Fiocco, Marta
    van de Sande, Michiel A. J.
    BMJ OPEN, 2017, 7 (02):
  • [36] A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma
    Roeder, Falk
    Schulz-Ertner, Daniela
    Nikoghosyan, Anna V.
    Huber, Peter E.
    Edler, Lutz
    Habl, Gregor
    Krempien, Robert
    Oertel, Susanne
    Saleh-Ebrahimi, Ladan
    Hensley, Frank W.
    Buechler, Markus W.
    Debus, Juergen
    Koch, Moritz
    Weitz, Juergen
    Bischof, Marc
    BMC CANCER, 2012, 12
  • [37] A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma
    Falk Roeder
    Daniela Schulz-Ertner
    Anna V Nikoghosyan
    Peter E Huber
    Lutz Edler
    Gregor Habl
    Robert Krempien
    Susanne Oertel
    Ladan Saleh-Ebrahimi
    Frank W Hensley
    Markus W Buechler
    Juergen Debus
    Moritz Koch
    Juergen Weitz
    Marc Bischof
    BMC Cancer, 12
  • [38] A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule
    L. Serrone
    M. Zeuli
    T. Gamucci
    M. Nardi
    F. Cognetti
    Cancer Chemotherapy and Pharmacology, 2001, 47 : 206 - 210
  • [39] A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule
    Serrone, L
    Zeuli, M
    Gamucci, T
    Nardi, M
    Cognetti, F
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (03) : 206 - 210
  • [40] Phase II study of neoadjuvant high-dose ifosfamide with concurrent radiotherapy followed by surgical resection in high -risk soft tissue sarcoma: A Spanish Group for Research on Sarcomas (GEIS) study
    Garcia del Muro, Xavier
    Lopez-Pousa, Antonio
    Jose Flor, Maria
    Redondo, Andres
    Cruz Jurado, Josefina
    Andres, Raquel
    Casado, Antonio
    Fra, Joaquin
    Lopez-Martin, Jose A.
    Maurel, Juan
    Maria Valverde, Claudia
    Gallego, Oscar
    Antonio Narvaez, Jose
    Bague, Silvia
    Sanjuan, Xavier
    Vinyals, Juan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345